Eloralintide And Tirzepatide
AMPLIFY-1
Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 2115
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Eloralintide And Tirzepatide
Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 2115
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.